Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.28, $0.02 better than the analyst estimate of $1.26. Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.89 billion.

Quest Diagnostics sees FY2015 EPS of $4.75-$4.80, versus the consensus of $4.76.

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.